Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 3, 1996, Pages 372-380

  Metzger, Randy E ^a   Ladu, Mary Jo ^b   Pan, Jia B ^a   Getz, Godfrey S ^b   Frail, Donald E ^a   Falduto, Michael T ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Human cerebral cortex; Immunohistochemistry; Low density lipoprotein receptor related protein; Microtubule associated proteins; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; MICROTUBULE ASSOCIATED PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CELLULAR DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID TRANSPORT; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0029995278     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199603000-00013     Document Type: Article

References (49)

1. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA 1985;82:203-7
2. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985;76:1501-13
3. Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Pathol 1994; 144: 1183-87
4. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-80
5. Murakami M, Ushio Y, Morino Y, Ohta T, Matsukado Y. Immunohistochemical localization of apolipoprotein E in human glial neoplasms. J Clin Invest 1988;872:177-88
6. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey II W, Haase AT. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 1991;65:4759-68
7. Han S-H, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994;128:13-26
8. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61
9. 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 1992;141:37-42
10. 2-microglobulin receptor/low-density lipoprotein receptor-related protein. Ann Neurol 1995;37:211-17
11. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE. Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neuntes by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 1992;33:1677-88
12. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-52
13. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31
14. Snipes GJ, McGuire CB, Norden JJ, Freeman JA. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 1986;83:1130-34
15. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72
16. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81
17. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research 1991;541:163-66
18. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-53
19. Benzing WC, Mufson EJ. Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to tau and phf in Alzheimer's disease. Exp Neurology 1995;132:162-71
20. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
21. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease - a primer for practicing pathologists, Arch Pathol Lab Med 1993;117:132-44
22. Rosene DL, Roy NJ, Davis BJ. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifacts. J Histochem Cytochem 1986;34:1301-15
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
24. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-48
25. Hay R, Getz GS. Translation in vivo and in vitro of proteins resembling apoproteins of rat plasma very low density lipoprotein. J Lipid Res 1979;20:334-48
26. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 1990;265:17401-4
27. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80
28. Hsu S-M, Raine L, Fanger H. A comparative study of the peroxidase-antiproxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75:734-38
29. Armstrong DM, Benzing WC, Evans J, Terry RD, Shields D, Hansen LA. Substance P and somatostatin coexist within neuritic plaques: Implications for the pathogenesis of Alzheimer's disease. Neuroscience 1989;31:663-71
30. Rall SC, Jr, Weisgraber KH, Mahley RW. Isolation and characterization of apolipoprotein E. Methods Enzymol 1986;128:273-87
31. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-98
32. Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-95
33. Gearing M, Rebeck GW, Hyman BT, Tigges J, Mirra SS. Neuropathology and apolipoprotein E profile of aged chimpanzees: Implications for Alzheimer disease. Proc Natl Acad Sci USA 1994;91: 9382-86
34. Mufson EJ, Benzing WC, Cole GM, et al. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques. Neurobiol Aging 1994,15:621-27
35. Wisniewski T, Frangione B. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-38
36. Han S-H, Einstein G, Weisgraber KH, et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J Neuropathol Exp Neurol 1994;53: 535-44
37. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-spccific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc Natl Acad Sci USA 1994;91:11183-86
38. Ye SQ, Olson LM, Reardon CA, Getz GS. Human plasma lipoproteins regulate apolipoprotein E secretion from a post-golgi compartment. J Biol Chem 1992;267:21961-66
39. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-6
40. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 1995;270:9039-42
41. Benzing WC, Mufson EJ. Alzheimer's disease subjects and controls displaying the apolipoprotein E ε4 allele are less likely to exhibit apoE immunoreactivity within temporal cortex pyramidal neurons. Soc Neurosci Abstr 1995;21:5
42. Lilly-Stauderman M, Brown TL, Balasubramaniam A, Harmony JAK. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells. J Lipid Res 1993;34:190-200
43. Ji Z-S, Fazio S, Lee Y-L, Mahley RW. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem 1994;269: 2764-72
44. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 1990;265:10771-79
45. Strittmattcr WJ, Weisgraber KH, Goedert M, et al. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurology 1994;125:163-71
46. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments Nature 1994;372:92-94
47. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 1994;94:860-69
48. Wisniewski T, Castaño EM, Golabek A, Vogel T, Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-35
49. Evans KC, Berger EP, Cho C. Weisgraber KH, Lansbury PT, Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 1995;92:763-67